SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Massardo, L.
Right arrow Articles by Jacobelli, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massardo, L.
Right arrow Articles by Jacobelli, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Occasional Series: Lupus Around the World The Chilean experience of systemic lupus erythematosus

L. Massardo

Departamento de Inmunologia Clínica y Reumatologia, Escuela de Medicina, Pontificia Universidad Católica de Chile

S. Jacobelli

Departamento de Inmunologia Clínica y Reumatologia, Escuela de Medicina, Pontificia Universidad Católica de Chile

The Chilean experience with SLE began more than 40 years ago. The first series was published in 1958 with 108 patients. Lupus hair was described for the first time as a symptom that highly suggested SLE at that time. Subsequent studies have dealt with differ ent clinical aspects of the disease. The description of silent nephropathy in SLE and inspira tory muscle dysfunction as a cause of unexplained dyspnoea have been relevant contributions to the understanding of this condition. Patient survival has improved over the last decades from 13% at 5 years in 1959 up to 87% in 1994. Reasons for this improved survival are probably related to better diagnosis and management of the severely ill patients. However, in spite of this, the incidence of infections in our patients often contrib utes to fatal outcome. Recently, some studies have been published related to the basic pathogenic mechanisms of this disease.

Key Words: Systemic Lupus erythematosus in Chile: Survival

Lupus, Vol. 5, No. 3, 175-177 (1996)
DOI: 10.1177/096120339600500302


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
M A Garcia, J C Marcos, A I Marcos, B A Pons-Estel, D Wojdyla, A Arturi, J C Babini, L J Catoggio, and D Alarcon-Segovia
Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients
Lupus, December 1, 2005; 14(12): 938 - 946.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
L. M. Vila, G. S. Alarcon, G. McGwin Jr, A. W. Friedman, B. A. Baethge, H. M. Bastian, B. J. Fessler, and J. D. Reveille
Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations
Rheumatology, March 1, 2004; 43(3): 358 - 363.
[Abstract] [Full Text] [PDF]



Advertisement